cdmo.directory
← Compare landing

Grifols Partnership vs Parimer Scientific

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryGrifols PartnershipParimer Scientific
SummaryCDMO specializing in small molecule injectable products, including concentrated and diluted parenteral formulations and intravenous solutions, leveraging 100+ years of Grifols expertise.U.S.-based CDMO offering chemical process development, analytical method development, and small-to-mid-scale GMP drug substance manufacturing. Founded in 2018, it serves startups, university researchers, and mid-size companies.
Services
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Biologics (Other)
  • Small Molecule
Development capabilities
  • Formulation development
  • Analytical method development
  • Formulation development
  • ICH stability testing
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Drug Substance (DS)
  • Max chemical: Pilot (10 kg – 100 kg)
  • DEA licensed
Locations
  • Headquarters, Sant Cugat del Vallès, Catalonia, Spain
  • U.S. GMP facility, United States
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Grifols Partnership alternatives · Parimer Scientific alternatives

Markdown mirror: /compare/grifols/parimer.md